Details of the Drug
General Information of Drug (ID: DMMUH98)
Drug Name |
9H-beta-Carboline-3-carboxylic acid propyl ester
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
beta-Ccp; 76808-18-9; beta-Carboline-3-carboxylic acid propyl ester; propyl beta-carboline-3-carboxylate; Pbc-3-C; propyl 9H-pyrido[3,4-b]indole-3-carboxylate; 9H-Pyrido(3,4-b)indole-3-carboxylic acid, propyl ester; C15H14N2O2; Beta CCP; Biomol-NT_000275; AC1Q2Y9C; AC1L3X2D; AC1Q66NN; .beta.-Carboline-3-carboxylic acid propyl ester; SCHEMBL2348263; 9H-B-CARBOLINE-3-CARBOXYLIC ACID PROPYL ESTER; CHEMBL274847; BPBio1_001101; CTK5E3459; CHEBI:93491; BDBM84992; DTXSID30227627; WGRVAGIQTHEEQW-UHFFFAOYSA-N; ZINC2391117; PDSP2_001744
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 254.28 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||